Literature DB >> 18780347

Membrane and membrane-associated proteins involved in the aggressive phenotype displayed by highly invasive cancer cells.

Paul Dowling1, Naomi Walsh, Martin Clynes.   

Abstract

Invasion, the penetration of tumour cells into adjacent tissues, is a fundamental characteristic of malignant carcinomas and a first step in the metastatic process. The molecular mechanisms involved in tumour cell invasion are complex, but over the last couple of decades the knowledge base has grown quite considerably and many proteins with important roles in invasion have been identified and characterised. Benign tumours typically are encapsulated, which inhibits their ability to behave in a malignant manner, meaning these tumours do not grow in a location-limited less aggressive manner, do not invade surrounding tissues and do not metastasise. The ability of malignant tumours to invade and metastasise is the major cause of death for cancer patients. A greater insight into the molecular basis of cancer invasion and metastasis will lead to the development of novel therapies and specific panels of biomarkers for use in the treatment and diagnosis/monitoring in many types of metastatic cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18780347     DOI: 10.1002/pmic.200800098

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  8 in total

1.  An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis.

Authors:  Piia-Riitta Karhemo; Suvi Ravela; Marko Laakso; Ilja Ritamo; Olga Tatti; Selina Mäkinen; Steve Goodison; Ulf-Håkan Stenman; Erkki Hölttä; Sampsa Hautaniemi; Leena Valmu; Kaisa Lehti; Pirjo Laakkonen
Journal:  J Proteomics       Date:  2012-07-17       Impact factor: 4.044

Review 2.  Plasma membrane proteomics and its application in clinical cancer biomarker discovery.

Authors:  Rikke Leth-Larsen; Rikke R Lund; Henrik J Ditzel
Journal:  Mol Cell Proteomics       Date:  2010-04-08       Impact factor: 5.911

3.  Comparative membrane proteomic analysis between lung adenocarcinoma and normal tissue by iTRAQ labeling mass spectrometry.

Authors:  Xuede Zhang; Wei Li; Yanli Hou; Zequn Niu; Yujie Zhong; Yuping Zhang; Shuanying Yang
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

Review 4.  Hsp90, an unlikely ally in the war on cancer.

Authors:  Jared J Barrott; Timothy A J Haystead
Journal:  FEBS J       Date:  2013-02-24       Impact factor: 5.542

5.  Metastasis-associated cell surface oncoproteomics.

Authors:  Piia-Riitta Karhemo; Maija Hyvönen; Pirjo Laakkonen
Journal:  Front Pharmacol       Date:  2012-11-07       Impact factor: 5.810

6.  Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis.

Authors:  Li Cui; Siliangyu Cheng; Xiaojun Liu; Diana Messadi; Yan Yang; Shen Hu
Journal:  Oncotarget       Date:  2016-12-13

7.  Stomatin‑like protein 2 induces metastasis by regulating the expression of a rate‑limiting enzyme of the hexosamine biosynthetic pathway in pancreatic cancer.

Authors:  Dang Chao; Kyohei Ariake; Satoko Sato; Hideo Ohtsuka; Tatsuyuki Takadate; Masaharu Ishida; Kunihiro Masuda; Shimpei Maeda; Takayuki Miura; Katsutaka Mitachi; Xun Jing Yu; Fumiyoshi Fujishima; Masamichi Mizuma; Kei Nakagawa; Takanori Morikawa; Takashi Kamei; Michiaki Unno
Journal:  Oncol Rep       Date:  2021-04-13       Impact factor: 3.906

8.  State of the art in tumor antigen and biomarker discovery.

Authors:  Klervi Even-Desrumeaux; Daniel Baty; Patrick Chames
Journal:  Cancers (Basel)       Date:  2011-06-09       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.